Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma
Open Access
- 20 June 2019
- journal article
- letter
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 105 (2) , e72-e75
Abstract
The objectives of these analyses were to examine cell-of-origin (COO) subtype distribution from multiple geographical locations globally, and assess the feasibility and efficiency of gene expression profiling (GEP) for patient selection from the ROBUST phase III randomized study of R 2-CHOP vs placebo/R-CHOP in patients with ABC-type diffuse large B-cell lymphoma. Diagnostic evaluation of COO subtype showed notable differences in the proportion of ABC-DLBCL incidences based on geographical origin and GEP analyses demonstrated rapid turnaround time to enable efficient patient classification and enrollment.Keywords
This publication has 15 references indexed in Scilit:
- Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysisPLOS ONE, 2018
- Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithmOncotarget, 2017
- The 2016 revision of the World Health Organization classification of lymphoid neoplasmsBlood, 2016
- Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue BiopsiesJournal of Clinical Oncology, 2015
- Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II StudyJournal of Clinical Oncology, 2015
- Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trialThe Lancet Oncology, 2014
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissueBlood, 2014
- Stromal Gene Signatures in Large-B-Cell LymphomasNew England Journal of Medicine, 2008
- The GCB subtype of diffuse large B-cell lymphoma is less frequent in Asian countriesLeukemia Research, 2007
- A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphomaProceedings of the National Academy of Sciences, 2003